Amatuximab (Anti-Mesothelin)

Amatuximab (Anti-Mesothelin) is a chimeric IgG1 monoclonal antibody against human mesothelin with potential anti-tumor activity. Amatuximab specifically targets mesothelin, a cell surface glycoprotein involved in cell adhesion and overexpressed in many epithelial-derived cancer cells. MW: 145.5 kD.

• Supplier: Selleck Chemicals
• Product #: A2401
• Sku #: A2401-1mg*25